中文

川宁生物 Revenue Breakdown

Period 2026-03-31 ・ Reported 2026-04-23
ItemAmountY/Y
Revenue¥1.09B-15.6%
Gross profit¥0.26B
Operating income¥0.14B
Net income¥0.11B-61.8%
Gross margin23.6%Net margin 10.1%
Revenue Q/Q-7.3%

Revenue Segments

The filing did not disclose a revenue breakdown for this period.

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥0.84B76.4%
R&D¥0.02B2.0%
SG&A¥0.06B5.9%
Tax & other¥0.03B3.0%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

华如科技真兰仪表朗坤科技西测测试美利信万得凯鑫宏业昆船智能智立方凡拓数创科瑞思威士顿

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies